Skip to main content
Fig. 1 (abstract P4). | Journal of Pharmaceutical Policy and Practice

Fig. 1 (abstract P4).

From: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies

Fig. 1 (abstract P4).

Number of units, average unit price of eculizumab (Soliris®) procured by the Brazilian Ministry of Health and the estimated number of treated patients from 2010-2018. * The average procurement price was calculated based in the different procurement processes through each year and number of units and the estimated number of treated patients per year was calculated based in the adults’ recommended daily doses for paroxysmal nocturnal haemoglobinuria (PNH)

Back to article page